The global Non-invasive cancer diagnostics market is expected to grow at the CAGR of 7.2% during 2017-2022. Rising chronic cancers with a growing demand of minimally invasive Diagnostics are driving the non-invasive cancer Diagnostics market across the globe. Non-invasive cancer diagnostic market is an approach used for detection of the cancer conditions with minimal incision in body during diagnosis. According to WHO, 14 million cases of cancer were reported and 8.2 million died in 2012. The numbers of fatalities have been increased to 8.8 million during 2015-16. This significant number of cancer cases has shifted the global attention towards the adoption of early detection and diagnosis techniques for cancer.

Request a free sample of our report on Non-Invasive Cancer Diagnosis Market: https://www.omrglobal.com/request-sample/non-invasive-cancer-diagnostics-market

Additionally, the growing awareness programs and initiatives by government and healthcare organizations are boosting the market growth across the globe. Cancer Research UK, the Department of Health, NHS England and Public Health England in collaboration has launched National Awareness and Early Diagnosis Initiative (NAEDI). The initiative aims to increase awareness of the signs and symptoms of cancer amongst the general public and medical professionals, and to promote early diagnosis. Many more number of such initiatives are creating awareness among global patients for diagnosis and treatment of cancer.

A full report of Non-Invasive Cancer Diagnosis Market Is available at https://www.omrglobal.com/industry-reports/non-invasive-cancer-diagnostics-market

Non-Invasive Cancer Diagnosis Market Segmentation

By type

Blood cancer

Solid tumors

Breast cancer

Lung cancer

Others

By techniques

Clinical chemistry

Immunochemistry/immunoassay

Molecular diagnostics

Other clinical instruments

Competitive landscape

Key strategies

Key company analysis

Regional analysis

North america

United states

Canada

Rest of north america

Europe

United kingdom

France

Germany

Italy

Spain

Rest of europe

Asia pacific

India

China

Japan

Rest of the world

Company profiles

A&g pharmaceutical, inc.

Introduction

A7g pharmaceutical product portfolio

A&g pharmaceutical recent activities

Accelerate brain cancer cure

Introduction

Accelerate brain cancer cure product portfolio

Accelerate brain cancer cure recent activities

Admera health innovations

Introduction

Admera health innovations product portfolio

Admera health innovations recent activities

Affymetrix inc.

Introduction

Affymetrix inc. Product portfolio

Affymetrix inc. Recent activities

Aviva biosciences corporation

Introduction

Aviva biosciences corporation product portfolio

Aviva biosciences corporation recent activities

Bioview inc.

Introduction

Bioview inc. Product portfolio

Bioview inc. Recent activities

Cynvenio biosystems

Introduction

Cynvenio biosystems product portfolio

Cynvenio biosystems recent activities

Digene corporation

Introduction

Digene corporation product portfolio

Digene corporation recent activities

Exosomics siena

Introduction

Exosomics siena product portfolio

Exosomics siena recent activities

Flariton health

Introduction

Flariton health product portfolio

Flariton health recent activities

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/non-invasive-cancer-diagnostics-market

About Us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404